000			02075 a2200637 4500
005			20250516023036.0
264		0	_c20110929
008			201109s 0 0 eng d
022			_a1873-5835
024	7		_a10.1016/j.leukres.2011.01.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Liang
245	0	0	_aRAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia. _h[electronic resource]
260			_bLeukemia research _cAug 2011
300			_a1020-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCase-Control Studies
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aChromosome Inversion
650	0	4	_aChromosomes, Human, Pair 16 _xgenetics
650	0	4	_aDNA, Neoplasm _xgenetics
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOncogene Proteins, Fusion _xgenetics
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPolymorphism, Restriction Fragment Length
650	0	4	_aRad51 Recombinase _xgenetics
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Rate
650	0	4	_aTranslocation, Genetic
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aYang, Lin
700	1		_aMi, Yingchang
700	1		_aWang, Jianxiang
700	1		_aLi, Jianyong
700	1		_aZhang, Yue
700	1		_aMa, Xiaotang
700	1		_aQin, Tiejun
700	1		_aXu, Zefeng
700	1		_aXiao, Zhijian
773	0		_tLeukemia research _gvol. 35 _gno. 8 _gp. 1020-6
856	4	0	_uhttps://doi.org/10.1016/j.leukres.2011.01.014 _zAvailable from publisher's website
999			_c20574840 _d20574840